RCAN3 and peripheral arterial disease: Our data showing that transcriptional and translational repression of RCAN3 by miR-17 and miR-20a enhances perfusion recovery in preclinical PAD models presents RCAN3 as a putative miR-17 and miR-20a target that regulates perfusion recovery in PAD.